John Adam Zangerle
Net Worth
Last updated:
What is John Adam Zangerle net worth?
The estimated net worth of Mr. John Adam Zangerle is at least $15,213,285 as of 15 Jun 2022. He owns shares worth $6,981,206 as insider, has earned $2,589,799 from insider trading and has received compensation worth at least $5,642,280 in STERIS plc.
What is the salary of John Adam Zangerle?
Mr. John Adam Zangerle salary is $940,380 per year as Senior Vice President, Gen. Counsel, Sec. in STERIS plc.
How old is John Adam Zangerle?
Mr. John Adam Zangerle is 58 years old, born in 1967.
What stocks does John Adam Zangerle currently own?
As insider, Mr. John Adam Zangerle owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
STERIS plc (STE) | Senior Vice President, Gen. Counsel, Sec. | 27,936 | $249.9 | $6,981,206 |
What does STERIS plc do?
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.
John Adam Zangerle insider trading
STERIS plc
Mr. John Adam Zangerle has made 7 insider trades between 2019-2022, according to the Form 4 filled with the SEC. Most recently he sold 2,659 units of STE stock worth $545,919 on 15 Jun 2022.
The largest trade he's ever made was exercising 12,252 units of STE stock on 1 Oct 2020. As of 15 Jun 2022 he still owns at least 27,936 units of STE stock.
STERIS key executives
STERIS plc executives and other stock owners filed with the SEC:
- Mr. Cary L. Majors (50) Senior Vice President of North America Commercial Operations
- Mr. Daniel A. Carestio (52) Pres, Chief Executive Officer & Director
- Mr. John Adam Zangerle (58) Senior Vice President, Gen. Counsel, Sec.
- Mr. Michael J. Tokich (56) Senior Vice President & Chief Financial Officer
- Mr. Walter M. Rosebrough Jr. (71) Chief Executive Officer Emeritus & Senior Advisor